Russell Investments Group, Ltd. Neuro Pace Inc Transaction History
Russell Investments Group, Ltd.
- $75.4 Billion
- Q2 2025
A detailed history of Russell Investments Group, Ltd. transactions in Neuro Pace Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 71,463 shares of NPCE stock, worth $776,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,463
Previous 44,916
59.1%
Holding current value
$776,088
Previous $552,000
44.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NPCE
# of Institutions
107Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$28.4 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$28.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$25.1 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$15 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$14.9 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $270M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...